48,493
edits
(One intermediate revision by the same user not shown) | |||
Line 127: | Line 127: | ||
| [[FATWO]], [[mesonephric adenocarcinoma]] | | [[FATWO]], [[mesonephric adenocarcinoma]] | ||
| Develops into vas deferens in males. | | Develops into vas deferens in males. | ||
| [[Image:Mesonephric duct remnant -- intermed mag.jpg|100px|thumb|center| | | [[Image:Mesonephric duct remnant -- intermed mag.jpg|100px|thumb|center|MR (WC)]] | ||
|- | |- | ||
|[[Walthard cell rest]] | |[[Walthard cell rest]] | ||
Line 156: | Line 156: | ||
**Round nucleus +/- nucleolus. | **Round nucleus +/- nucleolus. | ||
Images | ====Images==== | ||
*[http://path.upmc.edu/cases/case394.html Hilus cell hyperplasia (upmc.edu)]. | *[http://path.upmc.edu/cases/case394.html Hilus cell hyperplasia (upmc.edu)]. | ||
===IHC=== | |||
Features: | |||
*Inhibin +ve. | |||
*Calretinin +ve. | |||
*PLAP -ve. | |||
==Mesonephric duct remnant== | ==Mesonephric duct remnant== |
edits